| 臺大學術典藏 |
2022-07-11T07:48:57Z |
Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
|
HSIANG-FONG KAO; Liao, Bin-Chi; Huang, Yen-Lin; HUANG, HUAI-CHENG; Chen, Chun-Nan; Chen, Tseng-Cheng; Hong, Yuan-Jing; Chan, Ching-Yi; Chia, Jean-San; Hong, Ruey-Long |
| 臺大學術典藏 |
2022-05-14T23:35:11Z |
Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
|
HSIANG-FONG KAO; BIN-CHI LIAO; Huang, Yen Lin; HUAI-CHENG HUANG; Chun-Nan Chen; TSENG-CHENG CHEN; Hong, Yuan Jing; Chan, Ching Yi; JEAN-SAN CHIA; Hong, Ruey Long |
| 臺大學術典藏 |
2022-04-15T03:38:51Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang, Shih-Hung; Lu, Li-Chun; HSIANG-FONG KAO; Chen, Bang-Bin; Kuo, Ting-Chun; Kuo, Sung-Hsin; YU-WEN TIEN; Bai, Li-Yuan; Cheng, Ann-Lii; Yeh, Kun-Huei |
| 臺大學術典藏 |
2022-03-28T05:27:14Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang, Shih-Hung; Lu, Li-Chun; HSIANG-FONG KAO; Chen, Bang-Bin; Kuo, Ting-Chun; Kuo, Sung-Hsin; Tien, Yu-Wen; Bai, Li-Yuan; Cheng, Ann-Lii; Yeh, Kun-Huei |
| 臺大學術典藏 |
2021-10-21T23:27:09Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Lu, Li Chun; HSIANG-FONG KAO; BANG-BIN CHEN; TING-CHUN KUO; SUNG-HSIN KUO; YU-WEN TIEN; Bai, Li Yuan; ANN-LII CHENG; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-07-12T08:46:27Z |
Aggressive revascularization of acute internal carotid artery occlusion in patients with NIHSS > 20 and poor collateral circulation: Preliminary report
|
Li A.-H.; Wang Y.-H.; HSIANG-FONG KAO; Yang L.-H.; Chan L.; Chu S.-H.; Liu H.-M. |
| 臺大學術典藏 |
2021-07-12T08:46:27Z |
Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients
|
Chen I.C.; Hsu C.; Chen Y.C.; Chien S.F.; HSIANG-FONG KAO; Chang S.Y.; Hu F.C.; Yeh K.H. |
| 臺大學術典藏 |
2021-07-12T08:46:26Z |
EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer
|
HSIANG-FONG KAO; Lin C.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-12T08:46:26Z |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
HSIANG-FONG KAO; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-07-12T08:46:25Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W.; Hua K.-T.; Li K.-C.; HSIANG-FONG KAO; Hong R.-L.; Ko J.-Y.; Hsiao M.; Kuo M.-L.; Tan C.-T. |
